Materials
Specialty Chemicals
$23.63B
20K
Key insights and themes extracted from this filing
Q1 2024 revenue was $9.925B, a 3% decrease compared to $10.247B in Q1 2023. The decrease was primarily due to a 7% decrease in average sales prices, partially offset by a 3% increase in volumes driven by improved demand and a 1% increase from favorable foreign exchange impacts.
Net income attributable to the company shareholders was $471 million for the three months ended March 31, 2024, compared to $472 million for the three months ended March 31, 2023.
Cash used in operating activities was $114 million in Q1 2024, compared to cash provided by operating activities of $482 million in Q1 2023. The change was primarily due to a build in working capital, driven by higher volumes and prices across most segments.